The HIV/AIDS in Africa Project:

Seventy percent of patients in the Medicines Sans Frontieres HIV/AIDS project take ARV manufactured by generic companies in India. In addition to the importance of generic drugs in the supply of ARV, competition from generic drugs has been credited with reducing the cost of ARV for a single patient from as much as $15,000 USD per year to as ... ................
................